JP2019521137A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019521137A5 JP2019521137A5 JP2019501569A JP2019501569A JP2019521137A5 JP 2019521137 A5 JP2019521137 A5 JP 2019521137A5 JP 2019501569 A JP2019501569 A JP 2019501569A JP 2019501569 A JP2019501569 A JP 2019501569A JP 2019521137 A5 JP2019521137 A5 JP 2019521137A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- phenyl
- amino
- oxadiazol
- piperazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16020268 | 2016-07-13 | ||
| EP16020268.5 | 2016-07-13 | ||
| PCT/EP2017/067390 WO2018011201A1 (en) | 2016-07-13 | 2017-07-11 | Heteroaromatic modulators of the retinoid-related orphan receptor gamma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019521137A JP2019521137A (ja) | 2019-07-25 |
| JP2019521137A5 true JP2019521137A5 (enExample) | 2020-07-30 |
| JP7016344B2 JP7016344B2 (ja) | 2022-02-04 |
Family
ID=56511303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019501569A Expired - Fee Related JP7016344B2 (ja) | 2016-07-13 | 2017-07-11 | レチノイド関連オーファン受容体γの新規芳香族複素環系モジュレーター |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10662181B2 (enExample) |
| EP (1) | EP3484880B1 (enExample) |
| JP (1) | JP7016344B2 (enExample) |
| KR (1) | KR102490140B1 (enExample) |
| CN (1) | CN109476653B (enExample) |
| AU (1) | AU2017294969B2 (enExample) |
| BR (1) | BR112019000486A2 (enExample) |
| CA (1) | CA3030370A1 (enExample) |
| DK (1) | DK3484880T3 (enExample) |
| ES (1) | ES2834009T3 (enExample) |
| IL (1) | IL264141B (enExample) |
| MX (1) | MX383770B (enExample) |
| MY (1) | MY196990A (enExample) |
| PL (1) | PL3484880T3 (enExample) |
| PT (1) | PT3484880T (enExample) |
| RU (1) | RU2771280C2 (enExample) |
| SA (1) | SA519400868B1 (enExample) |
| SG (1) | SG11201811107WA (enExample) |
| UA (1) | UA123330C2 (enExample) |
| WO (1) | WO2018011201A1 (enExample) |
| ZA (1) | ZA201808436B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019000486A2 (pt) * | 2016-07-13 | 2019-04-24 | Leo Pharma A/S | composto, composição farmacêutica, e, método para prevenir, tratar ou melhorar psoríase |
| CN111825654A (zh) * | 2019-04-19 | 2020-10-27 | 北京酷瓴生物技术有限公司 | 苯甲烯哌啶衍生物及其制备方法、中间体和用途 |
| CN112898292A (zh) * | 2019-12-03 | 2021-06-04 | 微境生物医药科技(上海)有限公司 | 新型极光激酶抑制剂及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS244821B2 (en) | 1983-06-16 | 1986-08-14 | Boehringer Ingelheim Ltd | Production method of new substituted phenylalkyl(piperazinyl or homopiperazinyle)-prpylureas or thioureas |
| WO2004073612A2 (en) | 2003-02-13 | 2004-09-02 | Merck & Co. Inc. | Estrogen receptor modulators |
| FR2879381B1 (fr) | 2004-12-15 | 2008-12-26 | Thales Sa | Systeme de distribution quantique de cle de cryptage a variables continues |
| UA95071C2 (ru) * | 2005-04-04 | 2011-07-11 | Аб Сьянс | Замещенные производные оксазола и их применение как ингибиторов тирозинкиназы |
| EP2511275A1 (en) * | 2011-04-12 | 2012-10-17 | Bioprojet | Novel piperidinyl monocarboxylic acids as S1P1 receptor agonists |
| PE20151144A1 (es) | 2012-12-06 | 2015-08-02 | Glaxo Group Ltd | Moduladores de la orphan receptor gamma retinoides relacionados (ror - gamma) para uso en el tratamiento de las enfermedades autoinmunes e inflamatorias |
| CA2929194A1 (en) | 2013-11-05 | 2015-05-14 | F. Hoffmann-La Roche Ag | 5,6,7,8-tetrahydro-5,8-methanocinnoline derivatives as rorc modulators for the treatment of autoimmune diseases |
| KR20170012388A (ko) | 2014-05-28 | 2017-02-02 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 신규 화합물 |
| JP6759110B2 (ja) * | 2014-05-28 | 2020-09-23 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | 新規な化合物 |
| ES2716966T3 (es) | 2014-05-28 | 2019-06-18 | Glaxosmithkline Ip Dev Ltd | Derivados de piperazina como moduladores de ROR-gamma |
| BR112019000486A2 (pt) * | 2016-07-13 | 2019-04-24 | Leo Pharma A/S | composto, composição farmacêutica, e, método para prevenir, tratar ou melhorar psoríase |
-
2017
- 2017-07-11 BR BR112019000486-6A patent/BR112019000486A2/pt active Search and Examination
- 2017-07-11 ES ES17737284T patent/ES2834009T3/es active Active
- 2017-07-11 MX MX2019000361A patent/MX383770B/es unknown
- 2017-07-11 EP EP17737284.4A patent/EP3484880B1/en active Active
- 2017-07-11 PT PT177372844T patent/PT3484880T/pt unknown
- 2017-07-11 WO PCT/EP2017/067390 patent/WO2018011201A1/en not_active Ceased
- 2017-07-11 AU AU2017294969A patent/AU2017294969B2/en not_active Ceased
- 2017-07-11 MY MYPI2018002824A patent/MY196990A/en unknown
- 2017-07-11 CN CN201780043425.2A patent/CN109476653B/zh not_active Expired - Fee Related
- 2017-07-11 SG SG11201811107WA patent/SG11201811107WA/en unknown
- 2017-07-11 KR KR1020197003804A patent/KR102490140B1/ko active Active
- 2017-07-11 CA CA3030370A patent/CA3030370A1/en active Pending
- 2017-07-11 DK DK17737284.4T patent/DK3484880T3/da active
- 2017-07-11 RU RU2019103883A patent/RU2771280C2/ru active
- 2017-07-11 JP JP2019501569A patent/JP7016344B2/ja not_active Expired - Fee Related
- 2017-07-11 UA UAA201901406A patent/UA123330C2/uk unknown
- 2017-07-11 US US16/317,655 patent/US10662181B2/en active Active
- 2017-07-11 PL PL17737284T patent/PL3484880T3/pl unknown
-
2018
- 2018-12-13 ZA ZA2018/08436A patent/ZA201808436B/en unknown
-
2019
- 2019-01-08 IL IL264141A patent/IL264141B/en unknown
- 2019-01-13 SA SA519400868A patent/SA519400868B1/ar unknown
-
2020
- 2020-05-15 US US16/874,961 patent/US10934282B2/en not_active Expired - Fee Related